DNAPrint Genomics, Inc.
DNAG
$0.00
$0.000.00%
OTC PK
| 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | 09/30/2006 | |
|---|---|---|---|---|---|
| Net Income | 43.67% | 28.63% | 204.26% | 4.27% | -135.29% |
| Total Depreciation and Amortization | 5.19% | 11.14% | -18.48% | 116.31% | 117.53% |
| Total Amortization of Deferred Charges | -100.00% | -68.57% | -46.81% | -76.98% | -35.65% |
| Total Other Non-Cash Items | -2.24% | -35.93% | -2,267.53% | -13.63% | 1,085.32% |
| Change in Net Operating Assets | -106.88% | 90.51% | -124.08% | 257.09% | 523.59% |
| Cash from Operations | -9.76% | 43.30% | 40.25% | 66.32% | -12.87% |
| Capital Expenditure | 98.17% | 100.00% | 97.98% | -305.53% | -1,008.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 174.01% | -- |
| Cash from Investing | 1,640.64% | 4,722.35% | 2,066.60% | 141.82% | 81.07% |
| Total Debt Issued | -- | -- | -- | -75.20% | -70.85% |
| Total Debt Repaid | 14.32% | -11.55% | 13.94% | 65.09% | 24.25% |
| Issuance of Common Stock | -- | -73.61% | -67.08% | -79.17% | -77.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -427.52% | -119.53% | -200.86% | -82.65% | -92.35% |
| Foreign Exchange rate Adjustments | -- | 136.36% | 150.00% | 9,700.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.50% | -65.74% | 72.13% | -68.51% | -475.98% |